Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function
Open Access
- 2 March 2007
- journal article
- Published by Hindawi Limited in Cellular Microbiology
- Vol. 9 (8) , 1909-1921
- https://doi.org/10.1111/j.1462-5822.2007.00923.x
Abstract
Enteropathogenic Escherichia coli (EPEC) infection of the human small intestine induces severe watery diarrhoea linked to a rather weak inflammatory response despite EPEC's in vivo capacity to disrupt epithelial barrier function. Here, we demonstrate that EPEC flagellin triggers the secretion of the pro-inflammatory cytokine, interleukin (IL)-8, from small (Caco-2) and large (T84) intestinal epithelia model systems. Interestingly, IL-8 secretion required basolateral infection of T84 cells implying that flagellin must penetrate the epithelial barrier. In contrast, apical infection of Caco-2 cells induced IL-8 secretion but less potently than basolateral infections. Importantly, infection of Caco-2, but not T84 cells rapidly inhibited IL-8 secretion by a mechanism dependent on the delivery of effectors through a translocation system encoded on the locus of enterocyte effacement (LEE). Moreover, EPEC prevents the phosphorylation-associated activation of multiple kinase pathways regulating IL-8 gene transcription by a mechanism apparently independent of LEE-encoded effectors and four non-LEE-encoded effectors. Crucially, our studies reveal that EPEC inhibits the capacity of the cells to secrete IL-8 in response to bacterial antigens and inflammatory cytokines prior to disrupting barrier function by a distinct mechanism. Thus, these findings also lend themselves to a plausible mechanism to explain the absence of a strong inflammatory response in EPEC-infected humans.Keywords
This publication has 83 references indexed in Scilit:
- An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their disseminationProceedings of the National Academy of Sciences, 2006
- Enteropathogenic Escherichia coli (EPEC) effector-mediated suppression of antimicrobial nitric oxide production in a small intestinal epithelial model systemCellular Microbiology, 2005
- Keynote review: Epithelial and endothelial barriers in human disease☆Drug Discovery Today, 2005
- Targeting of Enteropathogenic Escherichia coli EspF to Host Mitochondria Is Essential for Bacterial PathogenesisJournal of Biological Chemistry, 2005
- EnteropathogenicEscherichia coli: unravelling pathogenesisFEMS Microbiology Reviews, 2005
- The Serine Protease Motif of EspC from Enteropathogenic Escherichia coli Produces Epithelial Damage by a Mechanism Different from That of Pet Toxin from Enteroaggregative E. coliInfection and Immunity, 2004
- Pathogenic Escherichia coliNature Reviews Microbiology, 2004
- Disruptionof Cell Polarity by Enteropathogenic Escherichia coli EnablesBasolateral Membrane Proteins To Migrate Apically and ToPotentiate PhysiologicalConsequencesInfection and Immunity, 2003
- A wide-host-range suicide vector for improving reverse genetics in Gram-negative bacteria: inactivation of the blaA gene of Yersinia enterocoliticaGene, 1991
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970